If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the time it has taken you to ...
The researchers also found that COPD patients have lower levels of NAD in the blood, which is associated with accelerated aging based on DNA methylation levels. Treatment with vitamin B3 resulted ...